drugset / Trial / NCT01106508
A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This first-in-human dose-escalation study is to characterize the safety, tolerability, pharmacokinetics and pharmacodynamics of LEQ506 given orally on a daily dosing schedule in patients with advanced solid tumors.
Timeline
- Start
- 2010-10
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LEQ506 | Small molecule | — | Oral |